Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Slomovitz, MD
Gynecologic Oncology Group
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- University of Miami - Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- John B. Amos Cancer Center
Columbus, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Maine Medical Center
Scarborough, Maine, United States
- Johns Hopkins
Baltimore, Maryland, United States
- University of Massachusetts Memorial Center
Worcester, Massachusetts, United States
- Sanford Clinic North - Bemidji
Bemidji, Minnesota, United States
- St. Dominic-Jackson Memorial Hospital
Jackson, Mississippi, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Memorial Medical Center-Cancer Center
Albuquerque, New Mexico, United States
- New Mexico Cancer Alliance
Albuquerque, New Mexico, United States
- Women'S Cancer Care Associates
Albany, New York, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- Sanford Roger Maris Cancer Center
Fargo, North Dakota, United States
- University Hospital Case Medical Center
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Magee Women'S Hospital of Upmc
Pittsburgh, Pennsylvania, United States
- Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- Sanford Medical Center - Sioux Falls
Sioux Falls, South Dakota, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 May 2015
- Primary completion
- 31 Jan 2018
- Completion
- 22 Aug 2024
- Last update posted
- 19 Sept 2024
- Registered enrollment
- 74
- Registry id
- NCT02228681
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.